Avidity Biosciences, Inc. revenue breakdown overview

Avidity Biosciences, Inc. revenue for the last year amounted to 9.56 M USD, the most of which — 9.56 M USD — came from its highest performing source at the moment, Antibody Oligonucleotide Conjugates, the year earlier bringing 9.22 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Avidity Biosciences, Inc. 9.56 M USD, and the year before that — 9.22 M USD.